CCO Oncology Podcast

Optimizing Therapy for Relapsed/Refractory Multiple Myeloma: Expert Answers to Your Questions

Episode Summary

In this podcast episode, listen to myeloma experts Suzanne Lentzsch, MD, PhD, and Saad Z. Usmani, MD, MBA, FACP, provide their thoughts on optimal treatment for relapsed/refractory multiple myeloma.

Episode Notes

In this podcast episode, Suzanne Lentzsch, MD, PhD, and  Saad Z. Usmani, MD, MBA, FACP, discuss how they select optimal treatment for relapsed/refractory (R/R) multiple myeloma (MM) and answer audience questions from a live webinar. Topics include:

• Selecting optimal triplet regimen after first relapse
• Sequencing treatment options after multiple relapses
• Managing patient expectations when selecting treatments
• Emerging treatment options for R/R MM

Presenters:  

Suzanne Lentzsch, MD, PhD
Director, Multiple Myeloma and Amyloidosis Program
Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Saad Z. Usmani, MD, MBA, FACP
Clinical Professor of Medicine
Department of Hematologic Oncology & Blood Disorders
Division Chief
Plasma Cell Disorders Division
Levine Cancer Institute/Atrium Health
Charlotte, North Carolina

Supported by educational grants from Amgen; Bristol-Myers Squibb; Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; and Oncopeptides.

Link to full program, including an downloadable slidesets and an on-demand webcast:
https://bit.ly/3gjr62p